Therapy-Related Acute Myelogenous Leukemia With an 11q23/MLL Translocation Following Adjuvant Cisplatin and Vinorelbine for Non–Small-Cell Lung Cancer

Abstract Cisplatin-based chemotherapy has become an accepted standard in the adjuvant treatment of Non–Small-cell lung cancer (NSCLC). We present a case of acute myelogenous leukemia with an 11q23/ MLL rearrangement diagnosed 1 year after the completion of 4 cycles of cisplatin and vinorelbine for resected NSCLC. To our knowledge, this is the first case of therapy-related acute myelogenous leukemia (t-AML) associated with this chemotherapy combination. The literature on t-AML with the 11q23/ MLL rearrangement is reviewed.